Although analysis of maternal plasma cell-free content has been employed for screening of
genetic abnormalities within a pregnancy, limited attention has been paid to its use for the …

Cell-free placental DNA (cfpDNA) is present in maternal circulation during gestation.
CfpDNA carries great potential as a research and clinical tool as it provides a means to …

Metabolic diseases affect a consistent part of the human population, leading to rising
mortality rates. This raises the need for diagnostic tools to monitor the progress of these …

Cell-free fetal DNA in the maternal circulation has been associated with the onset of labor at
term. Moreover, clinical studies have suggested that cell-free fetal DNA has value to predict …

cfDNA consists of degraded DNA fragments released into body fluids. Its genetic and
pathological information makes it useful for prenatal testing and early tumor detection …

Objective Mismatch between a depleted intrauterine environment and a substrate‐rich
postnatal environment confers an increased risk of offspring obesity and metabolic …

Background and Objectives: obesity and blood pressure disorders are one of the main risk
factors for antenatal, intra, postpartum, and neonatal complications. In preeclampsia (PE) …

It is currently unknown why obesity leads in some patients to prediabetes and metabolic
syndrome. Microinflammation potentially caused by extracellular DNA is supposed to be …

Epidemiological studies show that obesity during pregnancy affects more than half of the
pregnancies in the developed countries and is associated with obstetric problems and poor …